<DOC>
	<DOCNO>NCT02327156</DOCNO>
	<brief_summary>The investigator evaluate motor sensory block duration postoperative analgesic effect add dexmedetomidine levobupivacaine sub-Tenon 's anesthesia patient undergoing vitreoretinal surgery . Motor sensory block duration consider primary endpoint .</brief_summary>
	<brief_title>Dexmedetomidine Adjuvant Sub-Tenon 's Anesthesia</brief_title>
	<detailed_description>Background : The investigator evaluate motor sensory block duration postoperative analgesic effect add dexmedetomidine levobupivacaine sub-Tenon 's anesthesia patient undergoing vitreoretinal surgery . Motor sensory block duration consider primary endpoint . Methods : The investigator investigate 60 patient subject vitreoretinal surgery sub-Tenon 's anesthesia . The patient randomly divide equally 1 2 group confer local anesthesia ( LA ) solution use receive either 4 mL levobupivacaine 0.75 % plus hyaluronidase 15 IU dilute 1mL normal saline ( group L ) 4 mL levobupivacaine 0.75 % plus hyaluronidase 15 IU dexmedetomidine 20 Î¼g dilute 1mL normal saline ( group LD ) . The total volume LA solution use 5 mL . Motor block ( akinesia ) sensory block duration evaluate return normal motor sensory function . The sedation level assess surgery period 24 hour postoperatively together degree postoperative pain efficiency postoperative analgesia . The sleep quality first postoperative night assess use Consensus Sleep Diary ( CSD ) .</detailed_description>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Levobupivacaine</mesh_term>
	<criteria>inclusion criterion : satisfactory akinesia predictable surgical time le 3 hour inclusion criterion study incorporated patient young 18 year , patient single eye , history sleep apnea , severe cardiac disease , drug abuse contraindication LA .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Dexmedetomidine</keyword>
</DOC>